This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
A pragmatic trial to prevent heart failure with an SGLT2 inhibitor in patients with stable atherosclerosis or multiple cardiovascular risk factors: ERASE-HF Trial
CIHR · 2023 · Principal investigator
A pragmatic trial to prevent heart failure with an SGLT2 inhibitor in patients with stable atherosclerosis or multiple cardiovascular risk factors: ERASE-HF Trial
Principal investigators: Udell, Jacob A; Lindsay, Mary Patrice; Smith, Jeanette; Ross, Heather J; Solomon, Scott D
Keywords: Atherosclerosis; Biomarkers; Health Data; Heart Failure; Pragmatic Clinical Trial; Primary Prevention; Risk Factors; Sglt2 Inhibitor
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.